Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2007 Jul 24;54(2):171–178. doi: 10.1007/s10344-007-0122-2

Exposure to disease agents in the endangered Iberian lynx (Lynx pardinus)

Melody E Roelke 1, Warren E Johnson 2, Javier Millán 3,, Francisco Palomares 3, Eloy Revilla 3, Alejandro Rodríguez 3, Javier Calzada 4, Pablo Ferreras 5, Luis León-Vizcaíno 6, Miguel Delibes 3, Stephen J O’Brien 2
PMCID: PMC7087597  PMID: 32214935

Abstract

The Iberian lynx (Lynx pardinus) is the most endangered felid species in the world. Lynx populations have decreased dramatically in size and distribution in the last four decades, thus becoming increasingly vulnerable to catastrophic events such as epizooties. From 1989 to 2000, serum samples were obtained from 48 free-ranging lynx captured in the Doñana National Park (DNP, n = 31) and mountains of Sierra Morena (SM, n = 17) in southern Spain. Samples were tested for antibodies against Toxoplasma gondii, feline herpesvirus 1 (FHV-1), feline calicivirus (FCV), feline/canine parvovirus (FPV/CPV), feline coronavirus, feline immunodeficiency virus (FIV), feline leukaemia virus and canine distemper virus (CDV) and for FeLV p27 antigen, to document baseline exposure levels. Antibodies against T. gondii were detected in 44% of lynx, with a significantly greater prevalence in DNP (61%) than in SM (12%). In DNP, prevalence was significantly higher in adult (81%) than in juvenile and sub-adult (41%) lynx, but no such difference was observed in SM. Low prevalences (≤11%) of minimally positive titres were found for FHV-1, FCV and FPV/CPV. This, combined with the lack of evidence for exposure to CDV, FIV and FeLV, suggests that these lynx populations are naïve and might be vulnerable to a disease outbreak in the future. Because of the reduced size of lynx populations, the documented low level of genetic variation (particularly in the DNP population) coupled with the recently documented state of immune depletion in a majority of necropsied lynx, it is important to better understand the threat and potential impact that disease agents might pose for the conservation of this endangered species. Future surveillance programs must include possible disease reservoir hosts such as domestic cats and dogs and other wild carnivores.

Keywords: Andalusia, Conservation, Disease risk, Serosurvey, Spain

Introduction

The Iberian lynx (Lynx pardinus) is the most endangered felid species in the world (Nowell and Jackson 1996), with less than 200 individuals currently inhabiting only two localities 230 km apart in Andalusia, southern Spain, namely, Doñana and Sierra Morena (SM; Guzmán et al. 2004). The drastic reduction in numbers of its staple prey, the wild rabbit (Oryctolagus cuniculus), because of two viral diseases outbreaks (myxomatosis and rabbit haemorrhagic disease), have resulted in the reduction in lynx numbers and range contraction, and local extinction of the species throughout most of Spain (Villafuerte et al. 1994; Rodríguez and Delibes 2002). An increasing concern exists about the role of diseases as a threat for conservation of endangered species (e.g. Smith et al. 2006). It has been shown that infectious diseases can cause significant mortality in wild carnivore populations (e.g. the Ethiopian wolf Canis simiensis [Sillero-Zubiri et al. 1996] and the African lion Panthera leo [Roelke-Parker et al. 1996]) and can result in the species extinction (the black-footed ferret Mustela nigripes, Thorne and Williams 1988), especially when the population size is small and reservoir hosts are present in the area (de Castro and Bolker 2005). Diseases not only reduce survival but also reduce fitness and/or alter movement patterns of infected individuals (Scott 1988). The Iberian lynx apparently has experienced one or several Pleistocene demographic bottlenecks that reduced levels of mitochondrial sequence variation and levels of microsatellite size variation compared to most other wild felid species (Johnson et al. 2004). More recently, the Doñana population has suffered further loss of genetic variation because of inbreeding (Johnson et al. 2004). Inbreeding was recently proposed as a cause of the loss of effectiveness of the immune system observed in lynx (Peña et al. 2006). Thus, remnant populations of the Iberian lynx might be particularly vulnerable to a fatal epidemic.

Apart from descriptions of the lynx helminth and ectoparasite fauna (e.g. Rodríguez and Carbonell 1998; Pérez and Palma 2001; Vicente et al. 2003), there is limited published information concerning disease agents of importance to Iberian lynx populations. Lynx are known to suffer from tuberculosis caused by Mycobacterium bovis (bTB, Pérez et al. 2001; Martín-Atance et al. 2006). Peña et al. 2006 found direct evidence of active infection with M. bovis, Toxoplasma gondii, feline coronavirus (FCoV), feline calicivirus (FCV) and Chlamydophila sp. in 6 of 17 necropsied lynx (positive samples detected by histology, immunohistochemistry, immunofluorescense and/or polymerase chain reaction deoxyribonucleic acid techniques). The Iberian lynx has been recently found to host piroplasmids belonging to the genus Cytauxzoon (Luaces et al. 2005; Millán et al. 2007). However, it has not been established to what extent diseases are threats to the conservation of the Iberian lynx. In Switzerland, an analysis of causes of mortality in reintroduced Eurasian lynx (Lynx lynx) suggested that disease may have a serious impact on population dynamics as 18% of all deaths (13 of 72 lynx), but 40% of the radio-collared sub-set (6 of 15 deaths) were attributable to disease processes such as sarcoptic mange and feline panleukopaenia (FPL; Schmidt-Posthaus et al. 2002). In Spain, feline retrovirosis, parvovirosis, canine distemper and other viral diseases are fairly common in populations of domestic (e.g. Arjona et al. 2000; Decaro et al. 2006) and wild carnivores (e.g. Nieto et al. 1992; Gortazar 1999). In light of the potential importance of infectious diseases for the Iberian lynx, the goal of this study was to compare two surviving populations of Iberian lynx for evidence of exposure of lynx to seven feline viral agents and T. gondii, all known to be pathogenic in other species of felids.

Materials and methods

From 1989 through 2000, 57 blood samples were collected from 48 free-living Iberian lynx that were captured as part of ongoing ecological studies. Thirty-one lynx were sampled in Doñana National Park (DNP, Huelva province, 37°9′N 6°26′W) and 17 in SM (Jaén province, 38°13′N 4°11′W). Seven lynx were sampled twice and one lynx three times at 1- to 2-year intervals (all them in DNP). Lynx were captured with box traps or padded foot traps (Victor soft catch no. 1.5 and 2, Woodstream, Lititz, PA) and immobilised with a combination of ketamine (4.5 mg/kg; Imalgène, Merial, France) and xylazine hydrochloride (4.0 mg/kg; Rompun, Bayer, Germany; Ferreras et al 1994) or with tiletamine–zolazepam (5.0 mg/kg; Zoletil, Virbac, Spain). Age was estimated by tooth wear and an evaluation of facial, body and pelt features. Lynx were classified as juvenile (6 to 12 months), sub-adult (13 to 23 months) and adult (≥2 years) according to Ferreras et al. 2004. Whole blood was obtained from each by venipuncture of either cephalic, saphenous or jugular veins. Samples were collected in serum separator tubes and allowed to clot and then centrifuged at 2,000 rpm for 10 to 15 min; the serum was removed and kept frozen at −20°C until analysed. Serum samples were tested for antibodies against the following disease agents: T. gondii, FCV, FCoV, feline immunodeficiency virus (FIV), feline/canine parvovirus (FPV/CPV), feline leukaemia virus (FeLV), canine distemper virus (CDV), and feline herpesvirus 1 (FHV-1). Active infection with FeLV was determined by the enzyme-linked immunosorbent assay (ELISA) for antigen (p27) detection. For lynx sampled multiple times, only results from the last bleed date was used to calculate prevalences. Serologic test methods, numbers of lynx tested by each method, positive antibody thresholds and references for standard test procedures or manufacturer and catalogue number of the test kit used are summarised in Table 1 with the following modifications and clarifications. Indirect immunofluorescence assay (IFA) tests for feline enteric coronaviruses (FECV)/feline peritonitis virus (FIPV) were performed as described by Evermann et al. 1986. The IFA is a group-specific test that detects cross-reacting antibodies to FIPV, FECV, canine coronavirus and transmissible gastroenteritis virus of swine. The lowest serum dilution used was 1:25. Sera that consistently reacted at 1:25 or greater dilutions on repeat evaluations were considered positive. The presence of FIV antibodies was detected by immunoblot (Western blot) assays as described by Troyer et al. 2005. The serum (diluted 1:200) was tested against the viral proteins derived from isolates of the domestic cat, puma (Puma concolor) and African lion FIV using a chemiluminescence Western blot. Test results (developed on X-ray film) were scored manually as positive, indeterminate or negative based on the presence and intensity of antibody binding to the p24 gag capsid protein. Sera were tested for CDV-neutralizing antibodies against the Rockborne strain of CDV. Other than the FIV Western blot, the majority of assays (47 samples) were performed by the Washington Animal Disease Diagnostic Laboratory (WADDL) in Pullman, WA. A smaller set of ten lynx sera collected in SM from 1992 to 1995 were analysed in the Infectious Diseases Area, Faculty of Veterinary Medicine, University of Murcia, Spain.

Table 1.

Disease agents tested in free-ranging Iberian lynx sera, test method, threshold, and reference or manufacturer and kit number

Serologic tests run Number tested Laba Assayb Detects Criterion and titre References or manufacturerc, name and number of kit
Toxoplasma gondii 47 W IHA test IgG Positive ≥1:64 Lappin and Powell (1991)
10 S LA IgG Positive ≥1:25 Mazumder et al. (1988)
Feline herpesvirus-1 35 W VN test IgG Positive ≥1:4 Scott (1977)
10 S ELISA IgG Qualitative Eurovet: F107-AB02d
Feline calicivirus 34 W VN test IgG Positive ≥1:4 Scott (1977)
10 S ELISA IgG Qualitative Eurovet: F1008-AB02d
Feline/canine parvovirus 27 W IFA test IgG Positive ≥1:25 Scott et al. 1970
10 S ELISA IgG Qualitative Ingezim CPV© 15.CPV.K1e
Feline coronavirus 27 W IFA test IgG Positive ≥1:25 Evermann et al. 1986
10 S ELISA IgG Qualitative Ingezim FCoV© 16.FCV.K1e
Feline leukaemia virus 28 W ELISA Antigen p27 Qualitative Mia et al. 1981
10 S ELISA Antigen p27 Qualitative Ingezim FeLV-Das© 16.FLV.K2e
10 S ELISA IgG Qualitative Ingezim FeLV gp-70© 16.FLV.K1e
Feline immunodeficiency virus 28 N WB IgG Qualitative Troyer et al. 2005
28 W ELISA IgG Qualitative Barr et al. 1989
10 S ELISA IgG Qualitative Ingezim FIV© 16.FIV.K1e
Canine distemper virus 27 W VN test IgG Positive ≥1:64 OIE 2004
10 S ELISA IgG Qualitative Ingezim Moquillo IgG® 15.CDG.K1e

aN Laboratory of Genomic diversity, National Cancer Institute, Frederick, MD; S Faculty of Veterinary Medicine, University of Murcia, Spain; W Washington Animal Disease Diagnostic Laboratory, Washington State University, Pullman, WA

bELISA Enzyme-linked immunosorbent assay, IFA indirect immunofluorescence assay; IHA indirect haemagglutination, LA latex agglutination, VN virus neutralisation, WB Western blot

cEurovet Veterinaria (d), Daganzo-Madrid, Spain; Ingenasa (e), Madrid, Spain.

Results

Twenty-one lynx were found to present antibodies against T. gondii (44%, Table 2). Antibody titres ranged from 1:64 to 1:2048. Antibodies were also found against FHV-1, FCV and FPV/CPV, with prevalences less than or equal to 11%. Antibodies against CDV, FCoV, FeLV and FIV and the FeLV p27 antigen were not detected (Table 2). The ten lynx captured in SM between 1992 and 1995 and tested in Spain resulted in two seropositive tests (T. gondii and FPV/CPV). FHV, with minimal titres (1:4), was only sporadically evident in the populations in 1994–1995 and 1998–1999, mostly in younger lynx. Prevalence of antibodies against T. gondii was higher in DNP (61%) than in SM (12%; Fisher exact p = 0.03), even if only adult individuals were included into the analysis (Fisher exact p = 0.001). Prevalence was greater in the adult (81%) than in the young lynx in DNP (juveniles + sub-adults, 41%; χ 2 = 8.1, p < 0.01). No such age-related differences were found in SM. Among the eight individuals that were sampled more than once over time in DNP, we documented three cases of sero-conversion from negative to positive, and one with a low titre became seronegative 2 years later (Table 3).

Table 2.

Sero-evidence of exposure to infectious disease agents in free-ranging Iberian lynx

  Sierra Morena (%) Doñana NP (%) Total (%)
Toxoplasma gondii 11.7 (2/17) 61.0 (19/31) 44.0 (21/48)
Feline herpesvirus 6.2 (1/16) 13.8 (4/29) 11.1 (5/45)
Feline calicivirus 6.2 (1/16) 3.6 (1/28) 4.5 (2/44)
Feline parvovirus 6.2 (1/16) 0 (0/21) 2.6 (1/37)
Feline coronavirus 0 (0/16) 0 (0/21) 0 (0/37)
Feline leukaemia virus 0 (0/17) 0 (0/21) 0 (0/38)
Feline immunodeficiency virus 0 (0/17) 0 (0/21) 0 (0/38)
Canine distemper virus 0 (0/16) 0 (0/21) 0 (0/37)

Prevalence in percent (positive/sampled)

Table 3.

Levels of antibody titers to Toxoplasma gondii in eight Iberian lynx that were sampled multiple times at different ages during their life

Name Juvenile Sub-adult Sub-adult, sampled later Adult Adult, sampled ≥1 year later
Ajoli 1:128 (1991) 1:1024 (1992)
Algaida 1:2048 (1991) 1:256 (1996)
Barro Neg (1996) 1:128 (1997)
Borja 1:512 (1993) 1:256 (1995)
Escarlata 1:128 (1994) Neg (1996)
Ganga Neg (1989) 1:256 (1991) 1:256 (1992)
Pepe 1:128 (1993) 1:128 (1994)
Uda Neg (1996) 1:64 (1997)

The sampling year is shown in parentheses.

Discussion

With the exception of T. gondii, seroprevalence of antibodies against infectious disease agents found in the present study was very low. This agrees with studies in other species of lynx, e.g. Eurasian lynx (Ryser-Degiorgis et al. 2005), Canada lynx (L. canadensis; Biek et al. 2002) or bobcat (L. rufus; Riley et al. 2004), as well in other species of solitary felids as the European wildcat (Felis silvestris; Daniels et al. 1999; Leutenegger et al. 1999). As observed by Ryser-Degiorgis et al. 2005 and Biek et al. 2002, we believe that the solitary social system of wild Iberian lynx limits the frequency of intra-specific contacts and thus keeps the possibility of disease transmission at a low level.

Almost half of the lynx were seropositive for T. gondii. Actual exposure rates to this parasite may be slightly underestimated as the indirect haemagglutination method employed in this study detects only IgG antibodies in feline serum, thus would have missed early infections with only IgM antibodies present (Lappin and Powell 1991). High prevalence of antibodies against T. gondii are commonly observed in free-living individuals of other lynx species (Ryser-Degiorgis et al. 2006 and review therein). As in other lynx species, it is likely that Iberian lynx are infected after exposure to infected prey. As aforementioned, wild rabbits constitute more than 85% of the Iberian lynx food base (Delibes 1980; Gil-Sánchez et al. 2006). In Huelva province (where DNP is found), antibodies against T. gondii were detected in 17% of wild rabbits (Almería et al. 2004). No data are available for SM, but the seroprevalence in the nearby province of Toledo was 12% (Almería et al. 2004). Thus, rabbit is the most probable source of exposure to T. gondii, although transplacental or lactational infection of kittens can also occur (Omata et al. 1994; Powell et al. 2001). An alternative source may be food or water contaminated by oocysts from cat faeces (Dubey and Odening 2001). We found that older lynx presented higher seroprevalence than young ones in DNP. In addition, three seronegative individuals were found to seroconvert when later re-sampled. Age-related differences in T. gondii infection rates as those observed in this study are common in wild Lynx species (e.g. Labelle et al. 2001; Zarnke et al. 2001; Kikuchi et al. 2004; Ryser-Degiorgis et al. 2006). Such age-related differences were not observed in the SM subpopulation, however, and the overall prevalence in this area was markedly lower than in DNP. Reasons for these differences are not apparent but may have been the result of insufficient sampling. Domestic cats are widespread in both areas. On the other hand, although exposure to T. gondii from rabbits might be lower in SM, there have been no studies of toxoplasmosis in rabbits in SM. Although T. gondii infection is common in felids, clinical toxoplasmosis is believed to be rare (Dubey et al. 1987). Peña et al. 2006 did not detect histopathological lesions associated to toxoplasmosis in two Iberian lynx found to be positive for T. gondii by means of the polymerase chain reaction. One of them was an adult male who was seropositive when live captured in 1991 and that died in 2002 with signs of bTB, suggesting that lynx are persistently infected with this species of Protozoa. However, toxoplasmosis has been proven fatal in neonatal bobcat (Dubey et al. 1987), and therefore a potential impact of T. gondii infection on Iberian lynx populations has to be considered.

Only one lynx from SM was found to be seropositive for cross-reacting antibodies to FPV/CPV. FPL, caused by FPV, is a highly contagious disease causing high mortality chiefly in young kittens, especially in case of stress or co-infection with other agents or parasites (Scott 1990). FPL has been reported in free-ranging bobcats (Wassmer et al. 1988) and in Eurasian lynx in Switzerland (Schmidt-Posthaus et al. 2002), and low prevalence of antibodies against FPV have been found in Eurasian lynx in Sweden (Ryser-Degiorgis et al. 2005), bobcats (Fox 1983) and Canada lynx (Biek et al. 2002). This low seroprevalence may indicate that contacts with the agent are rare or that mortality because of the infection is very high. Remarkably, in Florida panthers (P. concolor), where the prevalence of FPV antibodies is particularly high (78%) and 32% presented titres more than 1:5,000, no disease has ever been documented (Roelke et al. 1993). Infection with FPV is thought to occur by ingestion of the virus in faeces, vomitus or urine from infected individuals (Cotter 1980). Feral cats are the more likely reservoir host of parvovirus (Sleeman et al. 2001). However, some canine parvovirus antigenic variants are able to replicate and cause disease in cats (Truyen et al. 1996) and can be very common in certain cat populations (Ikeda et al. 2000). Thus, the domestic dog or the red fox (Vulpes vulpes) could be also considered a potential source of infection for the lynx (Barker et al. 1985). One concern is that FPV/CPV might be having a large, undocumented effect on Iberian lynx kittens, for which parvovirus is particularly harmful (Barker and Parrish 2001), which is not detected from the current process of sampling.

FHV and FCV are the etiological agents of most of the cases of respiratory disease in cats (Gaskell and Dawson 1998). Antibodies against FHV were detected in a low number of lynx in both study populations (DNP 14%, SM 6%). It is possible that we have under-reported the true number of antibody-positive animals in this study, as the viral neutralisation method used for the majority of the samples (by WADDL) has been shown to detect fewer positives than the ELISA method (66 vs 97%, respectively; Stiles 2000; Maggs et al. 1999). However, at least for the SM population, where an ELISA method was used for 60% of those sampled, the virus neutralisation results are comparable to the ELISA (one of seven positive vs zero of ten). In other Lynx species, FHV prevalences of 1% in Canada lynx (Biek et al. 2002) and no detection in bobcats (Riley et al. 2004) and Eurasian lynx (Ryser-Degiorgis et al. 2005) have been reported. Exposure to FHV has been also recorded in wildcats in different European locations, ranging from 0 to 16% (Artois and Remond 1994; Daniels et al. 1999; Leutenegger et al. 1999). Antibodies against FCV were detected in only two lynx, one from each location. Although this low prevalence is similar to that reported in Canada (Biek et al. 2002) or in Eurasian lynx (Ryser-Degiorgis et al. 2005), this virus was found to be quite common in bobcats as reported by Riley et al. 2004. In European wildcat, seroprevalence of FCV ranges from 16 to 37% (Artois and Remond 1994; Daniels et al. 1999; Leutenegger et al. 1999). Transmission of FHV and FCV occurs via close contact and transmission of body fluids, particularly respiratory secretions, and the virus remains viable in the environment for only a few hours or days (Gaskell and Dawson 1998). About half of the FHV-infected cats and almost all the FCV-infected cats are carriers that undergo dormant periods without shedding but renew shedding virus after stress situations (Gaskell and Dawson 1998; Williams and Barker 2001). Thus, the most likely source of FHV and FCV infection for the Iberian lynx may be domestic or feral cats. In agreement with this, Riley et al. 2004 observed that bobcats sampled in areas where cats were frequent presented a markedly higher seroprevalence of antibodies against FCV. As observed for T. gondii and FPV, the effect of FHV and FCV on Iberian lynx is unknown. However, these agents deserve attention because high mortality can be observed in kitten and immunosuppressed cats (Gaskell and Dawson 1998). There was no evidence of lynx exposure to FIV, FeLV, FCoV or CDV. FIV and FeLV require direct or intimate contact for transmission, and both can be lethal to the domestic cat (Courchamp et al. 1995). FCoV infection has had devastating effects on cheetahs (Acinonyx jubatus) in a number of captive facilities (Evermann et al. 1986; O’Brien et al. 1985). This higher susceptibility to this and other viral infections (i.e. FHV-1; Munson et al. 2004) is believed to be related to the species’ lack of genetic diversity compared to other species of cats (Evermann et al. 1986; O’Brien et al. 1985). The extant Iberian lynx population has even less genetic variability than the cheetah (Johnson et al. 2004), so may be similarly at risk if they were to encounter this virus. CDV, which has emerged as a felid pathogen, is especially problematic in species of the Panthera genus and caused significant mortality in lions in Serengeti National Park in Tanzania (Roelke-Parker et al. 1996). CDV was also a leading factor in the extinction in the wild of the black-footed ferret (Thorne and Williams 1988). Lack of evidence of exposure of lynx to these agents suggests that these populations might be vulnerable to an outbreak in the future. Moreover, additional factors, such as malnutrition or stress can exacerbate the effect of infectious agents (Murray et al. 1999).

Given the small number of Iberian lynx remaining in the wild, it is imperative that measures be taken to protect all individual lynx from potential pathogens wherever possible. As lynx are removed from the wild for rehabilitation or captive breeding, care must be taken to prevent transmission of disease agents from these individuals to the captive felid population or from captive animals to those which will be released and could potentially contaminate the free-ranging population (Roelke et al. 1991). Furthermore, it is important to understand the role of these pathogens in the environment. Surveillance for pathogens should be carried out in other sympatric species that may act as reservoir, especially the widespread cat, dog and fox. Consideration should also be given to the reduction in or vaccination of cat and dog populations in and around the remaining core populations of the Iberian lynx.

Acknowledgments

The research was supported by DGICYT and DGES (projects PB90-1018, PB94-0480 and PB97-1163), Consejería de Medio Ambiente de la Junta de Andalucía, Instituto Nacional para la Conservacion de la Naturaleza and US–Spain Joint Commission for Scientific and Technological Cooperation. We thank J.M. Fedriani and J.C. Rivilla for assistance in the captures of the lynx. Doñana National Park provided samples of some specimens. A. Rodríguez was supported by Junta de Andalucía. This publication has been funded in part with Federal funds from the National Cancer Institute, National Institutes of Health, under contract no. N01-CO-12400. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services nor does mention of trade names, commercial products or organisations imply endorsement by the US Government. This Research was supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research.

References

  1. Almería S, Calvete C, Pagés A, Gauss C, Dubey JP. Factors affecting the seroprevalence of Toxoplasma gondii infection in wild rabbits (Oryctolagus cuniculus) from Spain. Vet Parasitol. 2004;123:265–270. doi: 10.1016/j.vetpar.2004.06.010. [DOI] [PubMed] [Google Scholar]
  2. Arjona A, Escolar E, Soto I, Barquero N, Martín D, Gómez-Lucía E. Seroepidemiological survey of infection by feline leukemia virus and immunodeficiency virus in Madrid and correlation with some clinical aspects. J Clin Microbiol. 2000;38:3448–3449. doi: 10.1128/jcm.38.9.3448-3449.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Artois M, Remond M. Viral diseases as a threat to free-living wild cats (Felis silvestris) in continental Europe. Vet Rec. 1994;134:651–652. doi: 10.1136/vr.134.25.651. [DOI] [PubMed] [Google Scholar]
  4. Barker IK, Parrish CR. Parvovirus infections. In: Williams ES, Barker IK, editors. Infectious diseases of wild mammals. 3. Ames, IA: Iowa State University Press; 2001. [Google Scholar]
  5. Barker IK, Povey RC, Voigt DR. Response of mink, skunk, red fox and raccoon to inoculation with mink virus enteritis, feline panleukopenia and canine parvovirus and prevalence of antibody to parvovirus in wild carnivores in Ontario. Can J Comp Med. 1985;47:188–197. [PMC free article] [PubMed] [Google Scholar]
  6. Barr MC, Calle PP, Roelke ME, Scott FW. Feline immunodeficiency virus infection in nondomestic felids. J Zoo Wildl Med. 1989;20:265–272. [Google Scholar]
  7. Biek R, Zarnke RL, Gillin C, Wild M, Squires JR, Poss M. Serologic survey for viral and bacterial infections in western populations of Canada lynx (Lynx canadensis) J Wildl Dis. 2002;38:840–845. doi: 10.7589/0090-3558-38.4.840. [DOI] [PubMed] [Google Scholar]
  8. Cotter SM. Feline panleukopenia. In: Kirk RW, editor. Current veterinary therapy VII. Philadelphia, PA: Saunders; 1980. pp. 1286–1288. [Google Scholar]
  9. Courchamp F, Ponier D, Fromont E, Artois M. Impact of two feline retroviruses on natural populations of domestic cat. Mammalia. 1995;59:589–598. doi: 10.1515/mamm.1995.59.4.589. [DOI] [Google Scholar]
  10. Daniels MJ, Golder MC, Jarrett O, MacDonald DW. Feline viruses in wildcats from Scotland. J Wildl Dis. 1999;35:121–124. doi: 10.7589/0090-3558-35.1.121. [DOI] [PubMed] [Google Scholar]
  11. Decaro N, Martella V, Desario C, Bellacicco AL, Camero M, Manna L, d’Aloja D, Buonavoglia C. First detection of canine parvovirus type 2c in pups with haemorrhagic enteritis in Spain. J Vet Med Ser B. 2006;53:468–472. doi: 10.1111/j.1439-0450.2006.00974.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. de Castro F, Bolker B. Mechanisms of disease-induced extinction. Ecol Lett. 2005;8:117–126. doi: 10.1111/j.1461-0248.2004.00693.x. [DOI] [Google Scholar]
  13. Delibes M. Feeding ecology of the Spanish lynx in the Coto Doñana. Acta Theriol. 1980;25:309–324. [Google Scholar]
  14. Dubey JP, Odening K. Toxoplasmosis and related infections. In: Samuel WM, Pybus MJ, Kocan AA, editors. Parasitic diseases of wild mammals. 2. London: Mason; 2001. [Google Scholar]
  15. Dubey JP, Quinn WJ, Weinandy D. Fatal neonatal toxoplasmosis in a bobcat (Lynx rufus) J Wildl Dis. 1987;23:324–327. doi: 10.7589/0090-3558-23.2.324. [DOI] [PubMed] [Google Scholar]
  16. Evermann JF, Roelke ME, Briggs MB. Clinical and diagnostic features of feline coronavirus infections of cheetahs. Feline Pract. 1986;26:21–30. [Google Scholar]
  17. Ferreras P, Aldama JJ, Beltrán JF, Delibes M. Immobilization of the endangered Iberian lynx with xylazine- and ketamine-hydrochloride. J Wildl Dis. 1994;30(1):65–68. doi: 10.7589/0090-3558-30.1.65. [DOI] [PubMed] [Google Scholar]
  18. Ferreras P, Delibes M, Palomares F, Fedriani JM, Calzada J, Revilla E. Dispersal in the Iberian lynx: factors affecting the start, duration, distance and dispersal success. Behav Ecol. 2004;15:31–40. doi: 10.1093/beheco/arg097. [DOI] [Google Scholar]
  19. Fox JS (1983) Relationships of diseases and parasites to the distribution and abundance of bobcats in New York. Ph.D. dissertation, SUNY-ESF, Syracuse
  20. Gaskell R, Dawson S. Feline respiratory disease. In: Greene CE, editor. Infectious diseases of dog and cat. Pennsylvania: Saunders; 1998. pp. 11–24. [Google Scholar]
  21. Gil-Sánchez JM, Ballesteros-Duperon E, Bueno-Segura JF. Feeding ecology of the Iberian lynx Lynx pardinus in eastern Sierra Morena (Southern Spain) Acta Theriol. 2006;51:85–90. [Google Scholar]
  22. Gortazar C. Ecología y patología del zorro (Vulpes vulpes L.) en el Valle medio del Ebro. Zaragoza, Spain: Consejo de Protección de la Naturaleza de Aragón; 1999. [Google Scholar]
  23. Guzmán JN, García FJ, Garrote G, Pérez de Ayala R, Iglesias C. El lince ibérico (Lynx pardinus) en España y Portugal. Censo-diagnóstico de sus poblaciones. Madrid, Spain: Dirección General para la Biodiversidad, Ministerio de Medio Ambiente; 2004. [Google Scholar]
  24. Ikeda Y, Mochizuki M, Naito R, Nakamura K, Miyazawa T, Mikami T, Takahashi E. Predominance of canine parvovirus (CPV) in unvaccinated cat populations and emergence of new antigenic types of CPVs in cats. Virology. 2000;278:13–19. doi: 10.1006/viro.2000.0653. [DOI] [PubMed] [Google Scholar]
  25. Johnson WE, Godoy JA, Palomares F, Delibes M, Fernandes M, Revilla E, O’Brien SJ. Phylogenetic and phylogeographic analysis of Iberian lynx populations. J Heredity. 2004;95:19–28. doi: 10.1093/jhered/esh006. [DOI] [PubMed] [Google Scholar]
  26. Kikuchi Y Chomel BB, Kasten RW, Martenson JS, Swift PK, O’Brien SJ. Seroprevalence of Toxoplasma gondii in American free-ranging or captive pumas (Felis concolor) and bobcats (Lynx rufus) Vet Parasitol. 2004;120:1–9. doi: 10.1016/j.vetpar.2004.01.002. [DOI] [PubMed] [Google Scholar]
  27. Labelle P, Dubey JP, Mikaelian I, Blanchette N, Lafond R, St-Onge S, Martineau D. Seroprevalence of antibodies to Toxoplasma gondii in lynx (Lynx canadensis) and bobcats (Lynx rufus) from Quebec, Canada. J Parasitol. 2001;87:1194–1196. doi: 10.1645/0022-3395(2001)087[1194:SOATTG]2.0.CO;2. [DOI] [PubMed] [Google Scholar]
  28. Lappin MR, Powell CC. Comparison of latex agglutination, indirect hemagglutination, and ELISA techniques for the detection of Toxoplasma gondii-specific antibodies in the serum of cats. J Vet Intern Med. 1991;5:299–301. doi: 10.1111/j.1939-1676.1991.tb03137.x. [DOI] [PubMed] [Google Scholar]
  29. Leutenegger CM, Hofmann-Lehmann R, Riols C, Liberek M, Worel G, Lups P, Fehr D, Hartmann M, Weilenmann P, Lutz H. Viral infections in free-living populations of the European wildcat. J Wildl Dis. 1999;35:678–686. doi: 10.7589/0090-3558-35.4.678. [DOI] [PubMed] [Google Scholar]
  30. Luaces I, Aguirre E, Garcia-Montijano M, Velarde J, Tesouro MA, Sanchez C, Galka M, Fernandez P, Sainz A. First report of an intraerythrocytic small piroplasm in wild Iberian lynx (Lynx pardinus) J Wildl Dis. 2005;41:810–815. doi: 10.7589/0090-3558-41.4.810. [DOI] [PubMed] [Google Scholar]
  31. Maggs DJ, Lappin MR, Reif JS, Collins JK, Carman J, Dawson DA, Bruns C. Evaluation of serologic and viral detection methods for diagnosing feline herpesvirus-1 infection in cats with acute respiratory tract or chronic ocular disease. J Am Vet Med Assoc. 1999;214:502–507. [PubMed] [Google Scholar]
  32. Martín-Atance P, León-Vizcaíno L, Palomares F, Revilla E, González-Candela M, Calzada J, Cubero-Pablo MJ, Delibes M. Antibodies to Mycobacterium bovis in wild carnivores from Doñana National Park (Spain) J Wildl Dis. 2006;42:704–708. doi: 10.7589/0090-3558-42.3.704. [DOI] [PubMed] [Google Scholar]
  33. Mazumder P, Chuang HY, Wentz MW, Wiedbrauk DL. Latex agglutination test for detection of antibodies to Toxoplasma gondii. J Clin Microbiol. 1988;26:2444–2446. doi: 10.1128/jcm.26.11.2444-2446.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Mia AS, Kahn DE, Tierney MM, Post JE. A microenzyme linked immunosorbent assay test for detection of FeLV in cats. Comp Immunol Microbiol Infect Dis. 1981;4:111–117. doi: 10.1016/0147-9571(81)90036-9. [DOI] [PubMed] [Google Scholar]
  35. Millán J, Naranjo V, Rodríguez A, Pérez de la Lastra JM, Mangold AJ, de la Fuente J. Prevalence of infection and 18S rRNA gene sequences of Cytauxzoon species in Iberian lynx (Lynx pardinus) in Spain. Parasitology. 2007;134:995–1001. doi: 10.1017/S003118200700248X. [DOI] [PubMed] [Google Scholar]
  36. Munson L, Wack R, Duncan M, Montali RJ, Boon D, Stalis I, Crawshaw GJ, Cameron KN, Mortenson J, Citino S, Zuba J, Junge RE. Chronic eosinophilic dermatitis associated with persistent feline herpes virus infection in cheetahs (Acinonyx jubatus) Vet Pathol. 2004;41:170–176. doi: 10.1354/vp.41-2-170. [DOI] [PubMed] [Google Scholar]
  37. Murray DL, Kapke CA, Evermann JF, Fuller TK. Infectious disease and the conswervation of free-ranging large carnivores. Anim Conserv. 1999;2:241–254. doi: 10.1111/j.1469-1795.1999.tb00070.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Nieto JM, Quiroga M, López M, Antonio RF. Distemper in mink in the NW of Spain. Nor J Agric Sci. 1992;9:398–404. [Google Scholar]
  39. Nowell K, Jackson P. Wild cats: status survey and conservation action plan. IUCN Publications. Cambridge, UK: Burlington; 1996. [Google Scholar]
  40. O’Brien SJ, Roelke ME, Marker L, Newman A, Winkler CA, Meltzer D, Colby L, Evermann JF, Bush M, Wildt DE. Genetic basis for species vulnerability in the cheetah. Science. 1985;227:428–434. doi: 10.1126/science.2983425. [DOI] [PubMed] [Google Scholar]
  41. OIE (2004) Manual of diagnostic tests and vaccines for terrestrial animals, 5th edn. World Organization for Animal Health. http://www.oie.int/eng/normes/mmanual/A_summry.htm
  42. Omata Y, Oikawa H, Kanda M, Midazuki K, Dilorenzo C, Claveria FG, Takahashi M, Igarashi I, Saito A, Suzuki N. Transfer of antibodies to kittens from mother cats chronically infected with Toxoplasma gondii. Vet Parasitol. 1994;52:211–218. doi: 10.1016/0304-4017(94)90113-9. [DOI] [PubMed] [Google Scholar]
  43. Peña L, García P, Jiménez MA, Benito A, Alenza MDP, Sánchez B. Histopathological and immunohistochemical findings in lymphoid tissues of the endangered Iberian lynx (Lynx pardinus) Comp Immunol Microbiol. 2006;29:114–126. doi: 10.1016/j.cimid.2006.01.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Pérez JM, Palma RL. A new species of Felicola (Phthiraptera: Trichodectidae) from the endangered Iberian lynx: another reason to ensure its survival. Biodivers Conserv. 2001;10:929–937. doi: 10.1023/A:1016688529572. [DOI] [Google Scholar]
  45. Pérez J, Calzada J, León-Vizcaíno L, Cubero MJ, Velarde J, Mozos E. Tuberculosis in an Iberian lynx (Lynx pardina) Vet Rec. 2001;148:414–415. doi: 10.1136/vr.148.13.414. [DOI] [PubMed] [Google Scholar]
  46. Powell CC, Brewer M, Lappin MR. Detection of Toxoplasma gondii in the milk of experimentally infected lactating cats. Vet Parasitol. 2001;102:29–33. doi: 10.1016/S0304-4017(01)00521-0. [DOI] [PubMed] [Google Scholar]
  47. Riley SP, Foley J, Chomel B. Exposure to feline and canine pathogens in bobcats and gray foxes in urban and rural zones of a national park in California. J Wildl Dis. 2004;40:11–22. doi: 10.7589/0090-3558-40.1.11. [DOI] [PubMed] [Google Scholar]
  48. Rodríguez A, Carbonell E. Gastrointestinal parasites of the Iberian lynx and other wild carnivores from central Spain. Acta Parasitol. 1998;43:128–136. [Google Scholar]
  49. Rodríguez A, Delibes M. Internal structure and contraction patterns in the geographic range of the Iberian lynx. Ecography. 2002;25:314–328. doi: 10.1034/j.1600-0587.2002.250308.x. [DOI] [Google Scholar]
  50. Roelke ME, Forrester DJ, Jacobson ER, Kollias GV (1991) Rationale for surveillance and prevention of infectious and parasitic disease transmission among free-ranging and captive Florida panthers (Felis concolor coryi). Proceedings of the Annual Conference of the American Association of Zoo Veterinarians, Philadelphia, PA
  51. Roelke ME, Forrester DJ, Jacobson ER, Kollias GV, Barr MC, Evermann JF, Pirtle EG. Seroprevalence of infectious disease agents in free-ranging Florida panthers (Felis concolor coryi) J Wildl Dis. 1993;29:36–49. doi: 10.7589/0090-3558-29.1.36. [DOI] [PubMed] [Google Scholar]
  52. Roelke-Parker ME, Munson L, Packer C, Kock R, Cleaveland S, Carpenter M, O’Brien SJ, Pospischil A, Hofmann-Lehmann R, Lutz H, Mwamengele GLM, Mgasa MN, Machange GA, Summers BA, Appel MJG. A canine distemper virus epidemic in Serengeti lions (Panthera leo) Nature. 1996;379:441–445. doi: 10.1038/379441a0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Ryser-Degiorgis MP, Hofmann-Lehmann R, Leutenegger CM, af Segerstad CH, Morner T, Mattsson R, Lutz H. Epizootiologic investigations of selected infectious disease agents in free-ranging Eurasian lynx from Sweden. J Wildl Dis. 2005;41:58–66. doi: 10.7589/0090-3558-41.1.58. [DOI] [PubMed] [Google Scholar]
  54. Ryser-Degiorgis MP, Jakubek EB, af Segerstad CH, Brojer C, Morner T, Jansson DS, Lunden A, Uggla A. Serological survey of Toxoplasma gondii infection in free-ranging Eurasian lynx (Lynx lynx) from Sweden. J Wildl Dis. 2006;42:182–187. doi: 10.7589/0090-3558-42.1.182. [DOI] [PubMed] [Google Scholar]
  55. Schmidt-Posthaus H, Breitenmoser-Wursten C, Posthaus H, Bacciarini L, Breitenmoser U. Causes of mortality in reintroduced Eurasian lynx in Switzerland. J Wildl Dis. 2002;38:84–92. doi: 10.7589/0090-3558-38.1.84. [DOI] [PubMed] [Google Scholar]
  56. Scott FW. Evaluation of a feline viral rhinotracheitis-feline calicivirus disease vaccine. Am J Vet Res. 1977;38:229–234. [PubMed] [Google Scholar]
  57. Scott ME. The impact of infection and disease on animal populations: implications for conservation biology. Conserv Biol. 1988;2:40–65. doi: 10.1111/j.1523-1739.1988.tb00334.x. [DOI] [Google Scholar]
  58. Scott FW. Feline parvovirus infection. In: Tijssen P, editor. Handbook of parvoviruses, vol. 2. Boca Raton, FL: CRC; 1990. pp. 103–111. [Google Scholar]
  59. Scott FW, Csiza CK, Gillespie JH. Maternally derived immunity to feline panleukopenia. J Am Vet Med Assoc. 1970;156:439–453. [PubMed] [Google Scholar]
  60. Sillero-Zubiri C, King AA, Macdonald DW. Rabies and mortality in Ethiopian wolves (Canis simensis) J Wildl Dis. 1996;32:80–86. doi: 10.7589/0090-3558-32.1.80. [DOI] [PubMed] [Google Scholar]
  61. Smith KF, Sax DF, Lafferty KD. Evidence for the role of infectious disease in species extinction and endangerment. Conserv Biol. 2006;20:1349–1357. doi: 10.1111/j.1523-1739.2006.00524.x. [DOI] [PubMed] [Google Scholar]
  62. Sleeman JM, Keane JM, Johnson JS, Brown RJ, Woude SV. Feline Leukemia Virus in a captive bobcat. J Wildl Dis. 2001;37:194–200. doi: 10.7589/0090-3558-37.1.194. [DOI] [PubMed] [Google Scholar]
  63. Stiles J. Feline herpesvirus. Vet Clin North Am Small Anim Pract. 2000;30:1001–1014. doi: 10.1016/s0195-5616(00)05003-8. [DOI] [PubMed] [Google Scholar]
  64. Thorne ET, Williams ES. Disease and endangered species: the black-footed ferret as a recent example. Conserv Biol. 1988;2:66–74. doi: 10.1111/j.1523-1739.1988.tb00336.x. [DOI] [Google Scholar]
  65. Troyer JL, Pecon-Slattery J, Roelke ME, Johnson W, VandeWoude S, Vazquez-Salat N, Brown M, Frank L, Woodroffe R, Winterbach C, Winterbach H, Hemson G, Bush M, Alexander KA, Revilla E, O’Brien SJ. Seroprevalence and genomic divergence of circulating strains of feline immunodeficiency virus among Felidae and Hyaenidae species. J Virol. 2005;79:8282–8294. doi: 10.1128/JVI.79.13.8282-8294.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Truyen U, Evermann JF, Vieler E, Parrish CR. Evolution of canine parvovirus involved loss and gain of Feline host range. Virology. 1996;215:186–189. doi: 10.1006/viro.1996.0021. [DOI] [PubMed] [Google Scholar]
  67. Vicente J, Palomares F, de Ibáñez RR, Ortiz J. Epidemiology of Ancylostoma spp. in the endangered Iberian lynx (Lynx pardinus) in the Doñana National Park, south-west Spain. J Helminthol. 2003;78:179–183. doi: 10.1079/JOH2003216. [DOI] [PubMed] [Google Scholar]
  68. Villafuerte R, Calvete C, Gortazar C, Moreno S. First epizootic of rabbit hemorrhagic disease in free living populations of Oryctolagus cuniculus at Doñana National Park, Spain. J Wildl Dis. 1994;30:176–179. doi: 10.7589/0090-3558-30.2.176. [DOI] [PubMed] [Google Scholar]
  69. Wassmer DA, Guenther DD, Layne JN. Ecology of the bobcat in South-Central Florida. Bull Fla State Mus, Biol Sci. 1988;3:159–228. [Google Scholar]
  70. Williams ES, Barker IK. Infectious diseases of wild mammals. Iowa: Iowa State University Press; 2001. [Google Scholar]
  71. Zarnke RL, Dubey JP, Ver Hoef JM, Mcnay ME, Kwok OCH. Serologic survey for Toxoplasma gondii in lynx from interior Alaska. J Wildl Dis. 2001;37:36–38. doi: 10.7589/0090-3558-37.1.36. [DOI] [PubMed] [Google Scholar]

Articles from European Journal of Wildlife Research are provided here courtesy of Nature Publishing Group

RESOURCES